For the two calendar years covering the roll-out of its toxic C19 mRNA injections, Moderna had sales of 37.5 billion bucks that cost it 8.6 billion bucks to make – leaving gross margin of around 29 billion bucks.
Continue reading Pfizer and Moderna Enter “Price Gouging” Phase?Day: March 27, 2023
Specialty Drug Cost Containment Strategy – The Indian Giver Method
Why would any payer cover something when they have only the slightest intention of doing so?
Continue reading Specialty Drug Cost Containment Strategy – The Indian Giver Method